Castlight Health (CSLT) Tops Q2 EPS by 2c
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Castlight Health (NYSE: CSLT) reported Q2 EPS of ($0.11), $0.02 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $23.6 million versus the consensus estimate of $23.09 million.
"In the second quarter Castlight added nearly $7 million of signed annual recurring revenue and continued to gain traction among large enterprises, including notable customers such as Caterpillar and Genentech," said Giovanni Colella, M.D., co-founder and chief executive officer of Castlight Health. "We had strong adoption of Castlight's health benefits platform across our new customers and saw increased contribution from our channel relationships, in particular Anthem, which provide validation of both our expanding value proposition and the evolution of our go-to-market strategy."
Castlight Health sees FY2016 EPS of ($0.40)-($0.42), versus the consensus of ($0.41). Castlight Health sees FY2016 revenue of $99-102 million, versus the consensus of $100.6 million.
For earnings history and earnings-related data on Castlight Health (CSLT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Caterpillar (CAT) Tops Q3 EPS by 8c, Sales Miss
- Watsco (WSO) Misses Q3 EPS by 11c; Guides Below the Street
- Freeport-McMoran (FCX) Misses Q3 EPS by 3c
Create E-mail Alert Related CategoriesEarnings, Guidance, Management Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!